Sectra enters the Greek market

The Swedish IT and medical-technology company Sectra has signed a distribution agreement with the Greek company Proton S.A., a provider of medical imaging and security systems based in Athens.

Sectra MicroDose Mammography
Sectra MicroDose Mammography

Through this partnership, Proton becomes a distributor of Sectra’s medical systems in Greece and Cyprus. The agreement includes all of Sectra’s products within medical systems.

“With Proton’s large customer base within radiology and existing sales and service network, we could not look for a better partner,” says Torbjörn Kronander, President of Sectra Imtec AB. “Proton has solid experience with products similar to Sectra’s, and this will significantly reduce the time for us to gain traction in the Greek market,” he continues.

In the near term, Proton will focus on sales of Sectra’s digital mammography system, Sectra MicroDose Mammography and Breast Imaging PACS (Picture Archiving and Communication System). The market for digital mammography in Greece is rapidly growing, with an increased awareness of the benefits of mammography in general and low-dose mammography in particular.

“The demand for digital mammography is growing in Greece,” says George Papaetis, President of Proton S.A. “With Sectra MicroDose Mammography, we can provide our customers with a highly efficient solution for mammography screening, at half the dose of competing systems. Moreover, we are positioning ourselves well for the expected increase in digitization of radiology, with an outstanding PACS solution in our offering,” he adds.


Read all latest stories

Related articles


Article • IT security

What keeps a hospital’s immune system healthy?

‘You can’t get 100 percent security, you can’t avoid all risks – but you can improve security tremendously just by considering some rules,’ explains Torbjörn Kronander, Board member, CEO…


Sponsored • Digital Pathology

Take the next step in Digital Pathology

Digitizing pathology is not just a transformation of technology, the major change and benefits lies in the change to a more efficient workflow – enabled by the new technology.


Sponsored • Testing Bones

Osteoporosis risk assessments with DXR

Women over the age of 50 are not only at higher risk of developing breast cancer but also osteoporosis. Would it not be practical to use the same method to detect both diseases early on? Definitely,…

Related products

Subscribe to Newsletter